BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16917866)

  • 1. Expression of DPC4/Smad4 gene in stone-containing intrahepatic bile duct.
    Lee KT; Chang WT; Wang SN; Chuang SC; Chai CY; Hu SW
    J Surg Oncol; 2006 Sep; 94(4):338-43. PubMed ID: 16917866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions.
    Harada K; Zen Y; Kanemori Y; Chen TC; Chen MF; Yeh TS; Jan YY; Masuda S; Nimura Y; Takasawa S; Okamoto H; Nakanuma Y
    Hepatology; 2001 May; 33(5):1036-42. PubMed ID: 11343228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma.
    Tang ZH; Zou SQ; Hao YH; Wang BJ; Yang XP; Chen QQ; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):624-9. PubMed ID: 14607700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
    Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
    Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
    Lee KT; Liu TS
    World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
    Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
    Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
    Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
    Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
    Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
    Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
    Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
    Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.
    Wang AG; Yoon SY; Oh JH; Jeon YJ; Kim M; Kim JM; Byun SS; Yang JO; Kim JH; Kim DG; Yeom YI; Yoo HS; Kim YS; Kim NS
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1022-32. PubMed ID: 16712791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
    Lee KT; Liu TS
    Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
    Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
    Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
    Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
    Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.